University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 21 of 35
Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial
NCT02966054
Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope
NCT03040466
Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing
NCT01849653
Decreasing Over Screening and Treatment of Cervical Precancers in Young Women
NCT02270021
Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma
NCT02116959
Cocaine Opioid Oxytocin Option - Limited
NCT02028533
Online Positive Emotion Skills Intervention for Symptoms of Depression
NCT01964820
Prospective Research of Outcomes After Salpingo-oophorectomy
NCT01948609
Independent Exercise Compared With Formal Rehabilitation Following Primary Total Knee Replacement
NCT01826305
Enhancing Motivation in Recent Onset Schizophrenia
NCT01817387
Examining the Effects of Diet on Health in Prediabetes With an Online Program
NCT02188823
GA-68 DOTA-TOC of Somatostatin Positive Malignancies
NCT02177773
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
NCT02168062
The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention
NCT02096757
ODEN Trial: Option vs. Denali IVC Filters
NCT02201277
Decisional Quality for Patients With Coronary Artery Disease
NCT02145481
Safety Study of TPI-287 to Treat CBS and PSP
NCT02133846
Optimizing Resilience and Coping in HIV Via Internet Delivery
NCT01997008
DuoPACT Pilot Intervention
NCT02181881
Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas
NCT01748149
Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer
NCT01804465
Meditation for Dementia Caregivers Major Depressive Disorder in Family Dementia Caregivers
NCT02122068
Pilot of Social Network Intrauterine Contraceptive (IUC) Intervention
NCT01965743
Glucagon Use in Colonoscopies
NCT02078726
Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder Treatment
NCT02125942
A Family-Based Approach To Reduce Smoking in Vietnamese Men
NCT02007707
Everolimus With and Without Temozolomide in Adult Low Grade Glioma
NCT02023905
Transforming Research and Clinical Knowledge in Traumatic Brain Injury
NCT02119182
Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation
NCT02088931
Therapeutic Resources for Attention Improvement With Neuroimaging for TBI
NCT02082509
The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II
NCT01979874
Comparison of Treatment for Hoarding Disorder
NCT02040805
Patient-Centered Care and Asian Americans
NCT02139722
Gardasil Immunogenicity With Needle-Free Injection
NCT01924754
Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis
NCT02040298
UCSF TARA Study: Training for Awareness, Resilience and Action
NCT02480257
Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes
NCT02023918
Text Messaging and Cognitive Behavioral Therapy for Depression
NCT01083628
Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus
NCT01781975
Fitness, Cellular Aging, and Caregiver Stress Study
NCT01993082
Endoscopic Surgery for Bariatric Revision After Weight Loss Failure
NCT01871896
HomeTech Healthy Lifestyle Program for Mothers With Young Children
NCT01819987
Butterfly Sensor With Rev K Version
NCT01992003
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
NCT01958320
Treatment of IPF With Laparoscopic Anti-Reflux Surgery
NCT01982968
Community-Based Cognitive Training in Early Schizophrenia
NCT01973270
Cardiovascular Assessment of the Effects of Tobacco and Nicotine Delivery Products
NCT01964807
Cognitive Effects of Anesthesia on Children
NCT02005185
Early Serum Infliximab Levels in Severe Ulcerative Colitis.
NCT01971814
Chronic Effects of DBS in Parkinson's Disease and Dystonia
NCT01934296
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.